CIK 0001357459 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 0 | ||
| Net income (USD) | -14.3 M | -26.6 M | ||
| Diluted EPS (USD/shares) | -0.3 | -27.01 | -16.53 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-07 | 4 | 4 | 2026-10-06 |
| 2026-10-07 | 4 | 4 | 2026-10-06 |
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-08-21 | 4 | 4 | 2026-08-19 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | 8-K | 8-K items 2.02,9.01 | 2026-08-10 |
| 2026-08-10 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-10 | 4 | 4 | 2026-07-08 |
| 2026-07-08 | 4 | 4 | 2026-07-06 |
| 2026-07-08 | 4 | 4 | 2026-07-06 |
| 2026-07-08 | 4 | 4 | 2026-07-06 |
| 2026-07-07 | 144 | 144 | |
| 2026-07-07 | 144 | 144 | |
| 2026-07-06 | 4 | 4 | 2026-07-01 |
| 2026-06-18 | 4 | 4 | 2026-06-10 |
| 2026-06-18 | 3 | 3 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 3 | 3 | 2026-06-10 |
| 2026-06-11 | 8-K | 8-K items 5.02,5.03,5.07,9.01 | 2026-06-10 |
| 2026-06-10 | S-8 | S-8 |
Forms on file (last 1,000): 8-K 269, 4 240, 10-Q 45, CORRESP 34, 424B3 33, EFFECT 24, 3 23, 425 22. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PALI (0.002 USD), /gw/filings/filings?ticker=PALI&form=8-K, /gw/filings/facts?ticker=PALI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange